Annual Revenue
$20.76 M
-$10.34 M-33.25%
December 31, 2023
Summary
- As of February 7, 2025, CCCC annual revenue is $20.76 million, with the most recent change of -$10.34 million (-33.25%) on December 31, 2023.
- During the last 3 years, CCCC annual revenue has fallen by -$12.44 million (-37.47%).
- CCCC annual revenue is now -54.67% below its all-time high of $45.78 million, reached on December 31, 2021.
Performance
CCCC Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$15.36 M
+$3.36 M+27.95%
September 30, 2024
Summary
- As of February 7, 2025, CCCC quarterly revenue is $15.36 million, with the most recent change of +$3.36 million (+27.95%) on September 30, 2024.
- Over the past year, CCCC quarterly revenue has increased by +$4.29 million (+38.75%).
- CCCC quarterly revenue is now -23.49% below its all-time high of $20.08 million, reached on December 31, 2021.
Performance
CCCC Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$33.67 M
+$4.29 M+14.60%
September 30, 2024
Summary
- As of February 7, 2025, CCCC TTM revenue is $33.67 million, with the most recent change of +$4.29 million (+14.60%) on September 30, 2024.
- Over the past year, CCCC TTM revenue has increased by +$13.32 million (+65.45%).
- CCCC TTM revenue is now -32.75% below its all-time high of $50.07 million, reached on June 30, 2022.
Performance
CCCC TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CCCC Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -33.3% | +38.8% | +65.5% |
| 3 y3 years | -37.5% | +38.8% | +65.5% |
| 5 y5 years | +7.2% | +38.8% | +65.5% |
CCCC Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -54.7% | at low | -23.5% | +476.6% | -32.8% | +110.0% |
| 5 y | 5-year | -54.7% | at low | -23.5% | +476.6% | -32.8% | +148.1% |
| alltime | all time | -54.7% | +7.2% | -23.5% | +476.6% | -32.8% | +527.7% |
C4 Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $15.36 M(+28.0%) | $33.67 M(+14.6%) |
| Jun 2024 | - | $12.01 M(+295.1%) | $29.38 M(+46.6%) |
| Mar 2024 | - | $3.04 M(-6.8%) | $20.04 M(-3.5%) |
| Dec 2023 | $20.76 M(-33.3%) | $3.26 M(-70.5%) | $20.76 M(+2.0%) |
| Sep 2023 | - | $11.07 M(+315.6%) | $20.35 M(+26.9%) |
| Jun 2023 | - | $2.66 M(-29.1%) | $16.03 M(-41.1%) |
| Mar 2023 | - | $3.76 M(+31.7%) | $27.20 M(-12.5%) |
| Dec 2022 | $31.10 M(-32.1%) | $2.85 M(-57.7%) | $31.10 M(-35.6%) |
| Sep 2022 | - | $6.75 M(-51.2%) | $48.32 M(-3.5%) |
| Jun 2022 | - | $13.83 M(+80.7%) | $50.07 M(+8.8%) |
| Mar 2022 | - | $7.65 M(-61.9%) | $46.01 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $45.78 M(+37.9%) | $20.08 M(+136.2%) | $45.78 M(+34.8%) |
| Sep 2021 | - | $8.50 M(-13.1%) | $33.97 M(+0.2%) |
| Jun 2021 | - | $9.78 M(+31.7%) | $33.92 M(+0.3%) |
| Mar 2021 | - | $7.43 M(-10.1%) | $33.80 M(+1.8%) |
| Dec 2020 | $33.20 M(+55.3%) | $8.26 M(-2.2%) | $33.20 M(+0.2%) |
| Sep 2020 | - | $8.45 M(-12.6%) | $33.14 M(+10.3%) |
| Jun 2020 | - | $9.67 M(+41.9%) | $30.06 M(+47.4%) |
| Mar 2020 | - | $6.82 M(-17.0%) | $20.39 M(+50.2%) |
| Dec 2019 | $21.38 M(+10.4%) | $8.21 M(+53.0%) | $13.57 M(+153.0%) |
| Sep 2019 | - | $5.36 M | $5.36 M |
| Dec 2018 | $19.36 M | - | - |
FAQ
- What is C4 Therapeutics annual revenue?
- What is the all time high annual revenue for C4 Therapeutics?
- What is C4 Therapeutics annual revenue year-on-year change?
- What is C4 Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for C4 Therapeutics?
- What is C4 Therapeutics quarterly revenue year-on-year change?
- What is C4 Therapeutics TTM revenue?
- What is the all time high TTM revenue for C4 Therapeutics?
- What is C4 Therapeutics TTM revenue year-on-year change?
What is C4 Therapeutics annual revenue?
The current annual revenue of CCCC is $20.76 M
What is the all time high annual revenue for C4 Therapeutics?
C4 Therapeutics all-time high annual revenue is $45.78 M
What is C4 Therapeutics annual revenue year-on-year change?
Over the past year, CCCC annual revenue has changed by -$10.34 M (-33.25%)
What is C4 Therapeutics quarterly revenue?
The current quarterly revenue of CCCC is $15.36 M
What is the all time high quarterly revenue for C4 Therapeutics?
C4 Therapeutics all-time high quarterly revenue is $20.08 M
What is C4 Therapeutics quarterly revenue year-on-year change?
Over the past year, CCCC quarterly revenue has changed by +$4.29 M (+38.75%)
What is C4 Therapeutics TTM revenue?
The current TTM revenue of CCCC is $33.67 M
What is the all time high TTM revenue for C4 Therapeutics?
C4 Therapeutics all-time high TTM revenue is $50.07 M
What is C4 Therapeutics TTM revenue year-on-year change?
Over the past year, CCCC TTM revenue has changed by +$13.32 M (+65.45%)